An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)
Clinical trial NCT01791153 · COMPLETED
Trial details
- NCT number
- NCT01791153
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-22
- Primary completion
- 2016-04-11
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.